Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines

Laryngoscope. 2012 Jun;122(6):1185-92. doi: 10.1002/lary.23261. Epub 2012 Mar 27.

Abstract

Objectives/hypothesis: Epithelial-derived interleukin (IL)-33 and thymic stromal lymphopoietin (TSLP) are critical regulators of innate and adaptive immune responses associated with Th2 cytokine-mediated inflammation, including allergic rhinitis. IL-33 and TSLP are expressed not only in epithelial cells but also fibroblasts, endothelial cells, and smooth muscle cells at nasal mucosal sites. However, the role and the regulation of IL-33 and TSLP in nasal fibroblasts remain unknown. We investigated the signal transduction regulation of IL-33 and TSLP induced by proinflammatory cytokines in nasal fibroblasts.

Study design: In vitro, prospective study.

Methods: Nasal fibroblasts were derived from human nasal mucosa without allergic rhinitis. Expression of IL-33 and TSLP was examined in nasal fibroblasts treated with proinflammatory cytokines IL-1β or tumor necrosis factor (TNF)-α after pretreatment with or without various inhibitors of signal transduction pathways.

Results: In nasal fibroblasts, both Western blotting and reverse transcriptase-polymerase chain reaction demonstrated that expression of mRNAs and proteins of IL-33 and TSLP was increased by treatment with IL-1β or TNF-α. Immunostaining revealed that IL-33-positive nuclei were markedly increased by the treatment with IL-1β or TNF-α. Enzyme-linked immunosorbent assay showed that fibroblast-released TSLP was significantly increased by treatment with IL-1β or TNF-α. The upregulation of both IL-33 and TSLP proteins by treatment with IL-1β was prevented by inhibitors of pan- protein kinase C (PKC), p38 mitogen-activated protein kinase, and nuclear factor (NF)-κB. In the cells treated with TNF-α, upregulation of IL-33 protein was prevented by inhibitors of phosphoinositide 3-kinase (PI3K), c-Jun N-terminal kinase (JNK), and NF-κB, whereas upregulation of TSLP protein was prevented by inhibitors of pan-PKC, PI3K, JNK, and NF-κB.

Conclusions: Expression of IL-33 and TSLP in nasal fibroblasts was regulated via distinct signal transduction pathways including NF-κB.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cells, Cultured
  • Cytokines / drug effects
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Humans
  • Immunohistochemistry
  • In Vitro Techniques
  • Interleukin-1beta / pharmacology*
  • Interleukin-33
  • Interleukins / metabolism*
  • Nasal Mucosa / cytology*
  • RNA, Messenger / analysis
  • Reference Values
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sampling Studies
  • Signal Transduction
  • Thymic Stromal Lymphopoietin
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Cytokines
  • IL33 protein, human
  • Interleukin-1beta
  • Interleukin-33
  • Interleukins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Thymic Stromal Lymphopoietin